Focus on Neurology and Psychiatry-logo

Focus on Neurology and Psychiatry

ReachMD

This special series explores new research and treatments in neuroscience and mental health.

This special series explores new research and treatments in neuroscience and mental health.
More Information

Location:

United States

Networks:

ReachMD

Description:

This special series explores new research and treatments in neuroscience and mental health.

Language:

English


Episodes

Could There Be a Secondary Cause for Your Patient's Migraine?

4/26/2018
More
Guest: Rashmi B. Halker Singh, MD, FAHS Join Dr. Rashmi B. Halker Singh, Assistant Professor of Neurology and Director of the Headache Fellowship Program at the Mayo Clinic, as she explains the importance of screening for red flags in a patient's headache. Dr. Singh also introduces mnemonic tools to help rule out secondary causes. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for...

Duration:00:04:29

The Multimodal Approach to Migraine Treatment

3/29/2018
More
Guest: Rashmi B. Halker Singh, MD, FAHS Focusing on a multimodal approach, Dr. Rashmi Singh, Director of the Headache Fellowship Program at the Mayo Clinic, discusses patient treatment options for those who suffer from migraines and provides an overview of the "SEEDS" approach to successful headache care. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care...

Duration:00:02:59

Overcoming Barriers to Migraine Prevention

3/19/2018
More
Guest: Stephanie Nahas, MD Dr. Stephanie Nahas, Director of the Headache Medicine Fellowship Program at Thomas Jefferson University, discusses potential roadblocks that can hamper migraine treatment and prevention. Rethinking Migraine is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Duration:00:03:29

How to Diagnose Migraines Faster in Primary Care Settings

3/19/2018
More
Guest: Stephanie Nahas, MD Dr. Stephanie Nahas, Director of the Headache Medicine Fellowship Program at Thomas Jefferson University, talks about methods to help diagnose migraine consistently and reliably in primary care settings. Rethinking Migraine is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Duration:00:02:59

Why Migraines Happen: Expert Insights on Disease Pathophysiology

3/14/2018
More
Guest: Stephanie Nahas, MD Dr. Stephanie Nahas, Director of the Headache Medicine Fellowship Program at Thomas Jefferson University, provides an overview of the physical impacts endured by the brain during migraines. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Duration:00:04:29

Patient Case: A Preventive Approach to Treating Migraines

3/13/2018
More
Guest: Jessica Ailani, MD From diagnosis to treatment, Dr. Jessica Ailani walks us through a migraine patient's case and discusses how she utilized a preventive therapeutic approach to reduce the frequency, duration, and severity of migraine episodes. Dr. Ailani is Associate Professor of Neurology at Georgetown University Hospital and Director of the MedStar Georgetown Headache Center. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational series is...

Duration:00:06:29

The Evolution of Migraine Theories

3/8/2018
More
Guest: Mark W. Green, MD Join us as Dr. Mark Green reviews the history of migraine theories, how they have evolved over time, and how each progressive insight has offered unique avenues toward treatment. Dr. Mark Green is a Professor of Neurology, Anesthesiology, and Rehabilitation Medicine and Director of Headache and Pain Medicine at the Icahn School of Medicine at Mount Sinai in New York, NY. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational...

Duration:00:04:30

Quality of Life Considerations for Your Migraine Patients

3/5/2018
More
Host: Andrew Wilner, MD Guest: Jessica Ailani, MD Migraines affect patients differently, but their impacts on daily life almost uniformly extend far beyond dealing with headache pain itself. For many, even basic day-to-day decisions that most take for granted will revolve around the fear of the next acute migraine attack. Join us as Dr. Jessica Ailani, Associate Professor of Neurology at Georgetown University Hospital and Director of the MedStar Georgetown Headache Center, shares how she...

Duration:00:10:30

High Price: How A Neuroscientist's Journey of Self-Discovery is Challenging Society's Perception on Drugs

2/19/2018
More
Host: Maurice Pickard, MD Guest: Carl Hart, MD Carl Hart, who grew up in one of Miami’s toughest neighborhoods, escaped a life of crime and drugs and avoided becoming one of the crack addicts he now helps treat as the Chair of the Department of Psychology at Columbia University. His landmark, controversial research is redefining our understanding of addiction and demonstrates how personal experience and scientific study can inform and validate each other for a deeper understanding of...

Duration:00:22:59

The Invisible Illness: Examining the Patient Impact of Migraines

2/12/2018
More
Guest: Stephanie Nahas, MD Migraines affect every aspect of a person's life but assessing the impact migraine has on a particular patient can prove to be challenging. Dr. Stephanie Nahas, Director, Headache Medicine Fellowship Program at Thomas Jefferson University talks about what doctors need to consider when assessing migraine patients. Rethinking Migraines is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is...

Duration:00:02:59

Innovations in MS: Mechanisms of Disease Progression and Immune Reconstitution

1/30/2018
More
Host: Matt Birnholz, MD Guest: Andrew Chan, MD Guest: Tobias Derfuss, MD Guest: Gavin Giovannoni, MBBCh, PhD Rapid advances in the management of multiple sclerosis reflects an evolving landscape whose emergent treatment philosophies are focused on improving both short- and long-term patient outcomes. This interview reviews different management strategies as well as the importance of personalized treatment, and what they mean for you and your patients. Join Professor Andrew Chan,...

Duration:00:13:29

Dr. Bennett Omalu on the Dangers of Concussions and CTE

1/19/2018
More
Host: Shira Johnson, MD Guest: Bennett Omalu, MD Many studies have demonstrated long-lasting and even permanent brain damage that can originate from just one concussion. With athletes suffering multiple repeated head traumas due to high-contact sports, the controversies over player safety and long-term health risks remain hot-button issues. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for chronic traumatic encephalopathy after autopsying American...

Duration:00:20:00

The Autopsy that Changed American Sports: Dr. Bennett Omalu and the Story of CTE

1/19/2018
More
Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that...

Duration:00:20:00

MS Pathogenesis: Understanding the Genetic & Environmental Triggers

12/15/2017
More
Host: Matt Birnholz, MD Guest: Gavin Giovannoni, MBBCh, PhD In this vital episode of On the Frontlines of Multiple Sclerosis, Dr. Matt Birnholz interviews Dr. Gavin Giovannoni, Professor of Neurology at Queen Mary University of London. Join us in examining the impact of genetic and environmental factors for MS, and how this information can influence MS diagnosis, management and treatment. This program has been brought to you through an independent educational grant from Merck KGaA,...

Duration:00:09:29

Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics

12/12/2017
More
Guest: Scott Newsome, DO, MSCS, FAAN The complexity and heterogeneity of multiple sclerosis (MS) pathogenesis renders its clinical course and response to therapy highly variable, particularly among special populations. This includes patients considering pregnancy or minority patients. This necessitates optimal strategies to personalize therapy and monitor disease activity and progression in special populations. This educational activity will review cutting-edge research on the unique...

Duration:00:14:30

Beyond Medication: Treatment Options for Drug-Resistant Epilepsy

12/11/2017
More
Host: David Weisman, MD It is estimated that approximately 30% of epilepsy patients are drug-resistant, meaning their seizures do not successfully respond to anti-seizure medications. What other treatment options are available to patients who aren’t responding to medication? Host Dr. David Weisman chats with Dr. Lara Marcuse, Co-Director of Mount Sinai Epilepsy Center, about new and emerging treatment options for epilepsy.

Duration:00:19:59

Headache Disorders: How Can We Better Manage the Pain?

12/8/2017
More
Host: Andrew Wilner, MD Guest: Merle Diamond, MD Treating primary headache disorders can frustrate patients and confound their physicians. However, science is catching up. We'll explore the complexity of the condition and the promise of new therapeutic approaches in an interactive update led by expert faculty: Merle L. Diamond, MD, with host Andrew Wilner, MD.

Duration:00:14:29

Altering the Collision Course: Protective Effects of Omega-3 Intake on Concussions

12/5/2017
More
Host: Brian P. McDonough, MD, FAAFP There is nearly a 20% chance that each of us will suffer a concussion this year. More concerning yet, over 30% of those concussions will lead to a long-term, potentially permanent disability. Many studies have explored how the use of Omega-3 fatty acids may add some measure of resilience within the brain to withstand injury in those at significant risk. Host Dr. Brian McDonough chats with Dr. Michael Lewis, founder of the nonprofit Brain Health...

Duration:00:13:59

Treating and Preventing Alzheimer’s Disease is Possible Using Functional Medicine

11/20/2017
More
Host: Kristi Hughes, ND Guest: David Perlmutter, MD In this interview, Dr. Kristi Hughes speaks with board-certified neurologist and New York Times bestselling author, David Perlmutter, about effective methods for preventing and treating cognitive decline. Dr. Perlmutter describes how lab tests you are already using can be used to assess patients with cognitive decline and Alzheimer’s disease. He outlines the important roles that systemic inflammation and gut health play in...

Duration:00:13:30

Neuromodulation Therapy: Emerging Treatment Option for Epilepsy beyond Medication

11/17/2017
More
Host: Andrew Wilner, MD While most people with epilepsy are treated with medications, other modalities such as surgery, diet, and neuromodulation are often necessary. Since the FDA approval of the vagus nerve stimulator in 1997, there has been a growing interest in neuromodulation. A second, more sophisticated device, the responsive neurostimulator, received FDA approval in 2013. Host Andrew Wilner talks with Dr. Robert Fisher, Professor of Neurology and Director of the Sandford Epilepsy...

Duration:00:16:29

Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Commercial-Free Music
No Display Ads